Interní Med. 2012; 14(5): 199-202

Bone care in older age

MUDr.Jiří Jenšovský
Interní klinika 1. LF UK, Osteocentrum, Ústřední vojenská nemocnice Praha &ndash, Střešovice

Bone care in the later decades of life requires a comprehensive approach involving evaluation of the patient’s clinical status along with

assessment of the potential risk of fractures. In this setting, the term “frailty syndrome” has been increasingly used. In preventing osteoporotic

fractures, it is always necessary to combine non-pharmacological intervention, nutritional intervention involving, in addition

to dietary measures, supplementation with calcium and particularly vitamin D or its analogues, and pharmacological treatment. In the

later decades of life, only a small number of medications have shown to have an effect in terms of evidence-based medicine.

Keywords: osteoporosis, frailty syndrome, calcium, vitamin D

Published: May 14, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jenšovský J. Bone care in older age. Interní Med. 2012;14(5):199-202.
Download citation

References

  1. Melton LJ, Kearns AE, Atkinson EJ, et al. Secular trends in hip fracture incidence and occurrence. Osteoporos Int, 2009; 20: 687-694. Go to original source... Go to PubMed...
  2. Birge SJ. Osteoporotic fractures - a brain or bone disease? Curr Osteoporos Rep, 2008; 6: 57-61. Go to original source... Go to PubMed...
  3. Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults- evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001; 56: M146-M156. Go to original source... Go to PubMed...
  4. American Geriatrics Society, British Geriatrics Society and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. Guideline for prevention of falls in older persons. J Am Geriatr Soc, 2001; 49: 664-672. Go to original source... Go to PubMed...
  5. Kannus P, Parkkari J, Koskinen S, et al. Fall-induced injuries and death among older adults. JAMA 1999; 281: 1895-1899. Go to original source... Go to PubMed...
  6. Sherrington C, Whitney JC, Lord SR, et al. Effective exercise for prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc, 2008; 56: 2234-2243. Go to original source... Go to PubMed...
  7. MacLaughlin J, Holick MF. Ageing decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76: 1536-1538. Go to original source... Go to PubMed...
  8. Lappe JM, Davies KM, Travers-Gustafson D, et al. Vitamin D status in a rural postmenopausal female populations. J Am Coll Nutr, 2006; 25: 393-402. Go to original source... Go to PubMed...
  9. Bischoff-Ferrari HA, Willet WC, Wong JB, et al. Fracture prevention with vitamin D supplementations: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-2264. Go to original source... Go to PubMed...
  10. Jackson RD, LaCroix AZ, Gass M, et al. Calcium and vitamin D supplementation and the risk of fractures. WHI Study Investigators. N Engl J Med, 2006; 354: 669-683. Go to original source... Go to PubMed...
  11. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older. Lancet 2007; 370: 657-666. Go to original source... Go to PubMed...
  12. Richy F, Dukas L, Schacht E. Differential effects of D hormone analogs and natice vitamin D on the risk of falls, a comparative meta-analysis. Calcif Tissue Int, 2008; 82: 102-107. Go to original source... Go to PubMed...
  13. Dukas l, Bischoff HA, Lindpainter L, et al. Alfacalcidol reduces the number of fallers in a community dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc, 2004; 52: 230-236. Go to original source... Go to PubMed...
  14. Dukas L, Schacht E, Mazor Z. Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with low creartinine clearence of less than 65ml/ min. Osteoporos Int, 2005; 16: 198-203. Go to original source... Go to PubMed...
  15. Inderjeeth CH, Foo ACH, Lai MMY, et al. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of evidence. Bone 2009; 44: 744-751. Go to original source... Go to PubMed...
  16. Hochberg MC, Thompson DE, Black DM, et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res, 2005; 20: 971-976. Go to original source... Go to PubMed...
  17. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zolendronic acid and clinical fractures and mortality after hip fracture. N Engl J Med, 2007; 357: 1799-1809. Go to original source... Go to PubMed...
  18. Boonen S. Osteoporosis in older persons. In: Duque G, Springer K (Ed). Medical treatment of age-related osteoporosis: present and future. London 2008: 137-152. Go to original source...
  19. Heaney RP. Is the paradigm shifting? Bone 2003; 33: 457-465. Go to original source... Go to PubMed...
  20. Rolland Y, VanKan GA, Gilette-guyonnet S, et al. Strontium ranelate and risk of vertebral fractures in rail osteoporotic women. Bone 2011; 48: 332-338. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.